Both in Management Consulting
Exponent vs Astrana Health
Over the past year EXPO returned +16.5% and ASTH returned +17.4%; their daily moves had a correlation of 0.11.
EXPO +16.5% ASTH +17.4%Growth of $1, one year, split-adjusted
| Metric | EXPO | ASTH |
|---|---|---|
| Price | $85.83 | $39.01 |
| Market cap | $4.08B | $1.94B |
| Today | −1.83% | −1.66% |
| 1 month | +24.5% | +5.0% |
| 6 months | +35.3% | +8.1% |
| Year to date | +23.6% | +57.2% |
| 1 year | +19.7% | +17.9% |
| Revenue growth (YoY) | +20.9% | +48.5% |
| Gross margin | 41.4% | 10.7% |
| Net margin | 17.1% | 2.0% |
| P/E (TTM) | 36.5× | 47.7× |
| Price / sales | 6.6× | 0.5× |
| Net cash | $66.6M | -$535.7M |
| Dividend yield | 1.44% | — |
| Volatility (60d) | 31.0% | 45.6% |
| Short % of float | 6.2% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).